Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 894.88 million compared to CNY 804.12 million a year ago. Revenue was CNY 896.02 million compared to CNY 807.69 million a year ago.

Net income was CNY 348.77 million compared to CNY 337.99 million a year ago. Basic earnings per share from continuing operations was CNY 0.6661 compared to CNY 0.6455 a year ago. Diluted earnings per share from continuing operations was CNY 0.6661 compared to CNY 0.6455 a year ago.